Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-103530
Filing Date
2025-08-06
Accepted
2025-08-06 07:08:40
Documents
91
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qttb-20250630.htm   iXBRL 10-Q 2968858
2 EX-31.1 qttb-ex31_1.htm EX-31.1 15493
3 EX-31.2 qttb-ex31_2.htm EX-31.2 15488
4 EX-32.1 qttb-ex32_1.htm EX-32.1 9593
5 EX-32.2 qttb-ex32_2.htm EX-32.2 9588
  Complete submission text file 0000950170-25-103530.txt   11467846

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT qttb-20250630.xsd EX-101.SCH 1719101
94 EXTRACTED XBRL INSTANCE DOCUMENT qttb-20250630_htm.xml XML 1892469
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38433 | Film No.: 251187422
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)